Community pharmacists' responses to drug-drug interaction alerts

American Journal of Health-System Pharmacy

Volumn 61, Issue 14, 2004, Pages 1484-1487

  Murphy, John E ^a,b   Forrey, Ryan A ^c   Desiraju, Usha ^d  

^a Dept of Pharm Practice and Science ^*  (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^d KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; POTASSIUM;

ARTICLE; COMPUTER SYSTEM; CONTROLLED STUDY; DATA BASE; DRUG INTERACTION; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INFORMATION PROCESSING; MANAGER; MEDICAL STUDENT; PHARMACIST; PHARMACY; PRIORITY JOURNAL; COMPUTER; HEALTH PERSONNEL ATTITUDE; MALE; UNITED STATES;

ARIZONA; ATTITUDE OF HEALTH PERSONNEL; COMPUTERS; DATA COLLECTION; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; PHARMACIES;

EID: 5144232664     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.14.1484     Document Type: Article

References (14)

1. Quinn DI, Day RO. Drug interactions of clinical importance: an updated guide. Drug Saf. 1995; 12:393-452.
2. Peterson JF, Bates DW. Preventable medication errors: identifying and eliminating serious drug interactions. J Am Pharm Assoc. 2001; 41:159-60.
3. Hansten PD. Drug interactions. 4th ed. Philadelphia: Lea & Febiger; 1979.
4. Hansten PD, Horn JR, Hazlet TK. ORCA: Operational classification of drug interactions. J Am Pharm Assoc. 2001; 41:161-5. Editorial.
5. Chrischilles E, Sorofman B, Zieglowsky MB et al. Iowa on-line prospective drug utilization review (OPDUR) demonstration project: study design, system design, and conceptual models. J Res Pharm Econ. 1997; 8:171-91.
6. Armstrong EP, Denemark CR. How pharmacists respond to online, real-time DUR alerts. J Am Pharm Assoc. 1998; 38: 149-54.
7. Dalton M, Chambers G, Halvachs F. Implementing an effective drug interaction reporting program. Hosp Pharm. 1999; 34:31-42.
8. Implementing effective change in meeting the demands of community pharmacy practice in the United States. Infusion. 1999; 5:43-8.
9. Bates DW, Leape LL. Pharmacies and prevention of potentially fatal drug interactions. JAMA. 1996; 275:1086-7. Letter.
10. Magnus D, Rodgers S, Avery AJ. GP's views on computerized drug interaction alerts: questionnaire survey. J Clin Pharm Ther. 2002; 27:377-82.
11. Abarca J, Malone DC, Armstrong EP et al. Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc. 2004; 44:136-41.
12. Hazlet TK, Lee TA, Hansten PD et al. Performance of community pharmacy drug interaction software. J Am Pharm Assoc. 2001; 41:200-4.
13. Chui MA, Rupp MT. Evaluation of online DUR programs in community pharmacy practice. J Manag Care Pharm. 2000; 6(1):27-32.
14. Malone DC, Abarca J, Hansten PD et al. Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. J Am Pharm Assoc. 2004; 44:142-51.